Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ram Yogev

Showing results (101-110 of 130) with videos related to

Pageof 13
Sort By:
AIDS (London, England)|February 18, 2015
Early viral suppression improves neurocognitive outcomes in HIV-infected childrenClaudia S Crowell, Yanling Huo, Katherine Tassiopoulos, et al.
The Pediatric Infectious Disease Journal|May 11, 2010
A chewable pediatric fixed-dose combination tablet of stavudine, lamivudine, and nevirapine: pharmacokinetics and safety compared with the individual liquid formulations in human immunodeficiency virus-infected children in ThailandNirun Vanprapar, Tim R Cressey, Kulkanya Chokephaibulkit, et al.
The Pediatric Infectious Disease Journal|October 12, 2011
Safety and immunogenicity of quadrivalent meningococcal conjugate vaccine in 2- to 10-year-old human immunodeficiency virus-infected childrenGeorge K Siberry, Meredith G Warshaw, Paige L Williams, et al.
Therapeutic Drug Monitoring|December 23, 2017
Comparative Analysis of Ampicillin Plasma and Dried Blood Spot Pharmacokinetics in NeonatesJennifer Le, Brenda Poindexter, Janice E Sullivan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 26, 2013
Indirect protection of adults from rotavirus by pediatric rotavirus vaccinationEvan J Anderson, Deanna B Shippee, Melissa H Weinrobe, et al.
Antimicrobial Agents and Chemotherapy|February 1, 2017
Pharmacokinetics of Clindamycin in Obese and Nonobese ChildrenMichael J Smith, Daniel Gonzalez, Jennifer L Goldman, et al.
Antiviral Therapy|December 14, 2011
Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected childrenKulkanya Chokephaibulkit, Tim R Cressey, Edmund Capparelli, et al.
The Pediatric Infectious Disease Journal|February 12, 2009
Early initiation of lopinavir/ritonavir in infants less than 6 weeks of age: pharmacokinetics and 24-week safety and efficacyEllen Gould Chadwick, Jorge Pinto, Ram Yogev, et al.
American Journal of Respiratory and Critical Care Medicine|September 2, 2020
Live-attenuated Vaccines Prevent Respiratory Syncytial Virus-associated Illness in Young ChildrenRuth A Karron, Jessica E Atwell, Elizabeth J McFarland, et al.
Antimicrobial Agents and Chemotherapy|July 16, 2008
Pharmacokinetics of high-dose lopinavir-ritonavir with and without saquinavir or nonnucleoside reverse transcriptase inhibitors in human immunodeficiency virus-infected pediatric and adolescent patients previously treated with protease inhibitorsBrian L Robbins, Edmund V Capparelli, Ellen G Chadwick, et al.
Pageof 13

Showing results (101-110 of 130) with videos related to

Sort By:
Pageof 13
AIDS (London, England)|February 18, 2015
Early viral suppression improves neurocognitive outcomes in HIV-infected childrenClaudia S Crowell, Yanling Huo, Katherine Tassiopoulos, et al.
The Pediatric Infectious Disease Journal|May 11, 2010
A chewable pediatric fixed-dose combination tablet of stavudine, lamivudine, and nevirapine: pharmacokinetics and safety compared with the individual liquid formulations in human immunodeficiency virus-infected children in ThailandNirun Vanprapar, Tim R Cressey, Kulkanya Chokephaibulkit, et al.
The Pediatric Infectious Disease Journal|October 12, 2011
Safety and immunogenicity of quadrivalent meningococcal conjugate vaccine in 2- to 10-year-old human immunodeficiency virus-infected childrenGeorge K Siberry, Meredith G Warshaw, Paige L Williams, et al.
Therapeutic Drug Monitoring|December 23, 2017
Comparative Analysis of Ampicillin Plasma and Dried Blood Spot Pharmacokinetics in NeonatesJennifer Le, Brenda Poindexter, Janice E Sullivan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 26, 2013
Indirect protection of adults from rotavirus by pediatric rotavirus vaccinationEvan J Anderson, Deanna B Shippee, Melissa H Weinrobe, et al.
Antimicrobial Agents and Chemotherapy|February 1, 2017
Pharmacokinetics of Clindamycin in Obese and Nonobese ChildrenMichael J Smith, Daniel Gonzalez, Jennifer L Goldman, et al.
Antiviral Therapy|December 14, 2011
Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected childrenKulkanya Chokephaibulkit, Tim R Cressey, Edmund Capparelli, et al.
The Pediatric Infectious Disease Journal|February 12, 2009
Early initiation of lopinavir/ritonavir in infants less than 6 weeks of age: pharmacokinetics and 24-week safety and efficacyEllen Gould Chadwick, Jorge Pinto, Ram Yogev, et al.
American Journal of Respiratory and Critical Care Medicine|September 2, 2020
Live-attenuated Vaccines Prevent Respiratory Syncytial Virus-associated Illness in Young ChildrenRuth A Karron, Jessica E Atwell, Elizabeth J McFarland, et al.
Antimicrobial Agents and Chemotherapy|July 16, 2008
Pharmacokinetics of high-dose lopinavir-ritonavir with and without saquinavir or nonnucleoside reverse transcriptase inhibitors in human immunodeficiency virus-infected pediatric and adolescent patients previously treated with protease inhibitorsBrian L Robbins, Edmund V Capparelli, Ellen G Chadwick, et al.
Pageof 13